Women damaged by pelvic mesh and families affected by the drug valproate are waiting for compensation two years after a report by England's Patient Safety Commissioner Henrietta Hughes. Hughes outlined steps the government should take to support these groups. Pelvic mesh is used in surgeries for stress urinary incontinence or pelvic organ prolapse and causes severe pain, inability to walk or work in some women. Valproate, commonly prescribed for epilepsy and bipolar disorder, has been linked to serious developmental problems in children exposed to the drug during pregnancy. Thousands of children exposed to valproate in utero have learning disabilities, physical disabilities, and many cannot lead independent lives. The report recommends that people injured by pelvic mesh or exposure to valproate should receive compensation.